Drug
Tenofovir Amibufenamide Tmf
Tenofovir Amibufenamide Tmf: highest development phase Post-Market, developed by Hansoh Pharmaceutical. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Hansoh Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tenofovir Amibufenamide（TMF） NCT06743438 | Post-Market | Hepatitis B, Chronic |
| Tenofovir Amibufenamide（TMF） NCT05797714 | Not Applicable | HBV Infection |
Latest
No recent events.
Follow Tenofovir Amibufenamide Tmf on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.